Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

(TIMP-2)x(IGFPB7) as Early Renal Biomarker for the Prediction of Acute Kidney Injury in Aortic Surgery - an Observational Study (TIGER)

NCT03469765 is registered in ClinicalTrials.gov with Jörg Schefold as lead sponsor.

NCT NCT03469765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03469765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
(TIMP-2)x(IGFPB7) as Early Renal Biomarker for the Prediction of Acute Kidney Injury in Aortic Surgery - an Observational Study (TIGER)
Lead sponsor
Jörg Schefold
Phase
Observational
Overall status
Completed
Start date
June 19, 2018
Completion date
September 23, 2019
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, aortic surgery, biomarker, dialysis, renal failure